Abstract
Multiple sclerosis is a chronic inflammatory autoimmune disease which affect central nervous system. Treatment initiation ofearly multiple sclerosis may postpone the development of disease progression and clinical activity, including magnetic resonancefindings and disablement.
The aims of this paper is to describe options for treating multiple sclerosis and risks.